Your browser is no longer supported. Please, upgrade your browser.
Settings
NGM NGM Biopharmaceuticals, Inc. daily Stock Chart
NGM [NASD]
NGM Biopharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.06 Insider Own1.40% Shs Outstand68.31M Perf Week6.10%
Market Cap1.33B Forward P/E- EPS next Y-1.44 Insider Trans496.83% Shs Float45.94M Perf Month3.63%
Income-71.60M PEG- EPS next Q-0.37 Inst Own63.50% Short Float8.73% Perf Quarter-12.69%
Sales96.80M P/S13.78 EPS this Y-70.60% Inst Trans5.27% Short Ratio18.32 Perf Half Y64.07%
Book/sh4.41 P/B4.34 EPS next Y0.70% ROA-19.40% Target Price30.78 Perf Year17.29%
Cash/sh4.48 P/C4.27 EPS next 5Y- ROE-22.20% 52W Range8.81 - 23.95 Perf YTD3.46%
Dividend- P/FCF- EPS past 5Y- ROI-14.90% 52W High-20.13% Beta-
Dividend %- Quick Ratio9.60 Sales past 5Y- Gross Margin- 52W Low117.14% ATR0.89
Employees186 Current Ratio9.60 Sales Q/Q-21.70% Oper. Margin-78.90% RSI (14)58.47 Volatility4.63% 4.82%
OptionableYes Debt/Eq0.00 EPS Q/Q-198.50% Profit Margin-74.00% Rel Volume2.13 Prev Close19.11
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume219.04K Price19.13
Recom1.70 SMA204.86% SMA503.82% SMA2006.29% Volume467,198 Change0.10%
Jul-31-20Initiated Piper Sandler Overweight $30
Jul-07-20Initiated Chardan Capital Markets Buy $40
Jun-05-20Initiated BMO Capital Markets Outperform $30
Apr-07-20Initiated Raymond James Strong Buy $31
Oct-17-19Initiated B. Riley FBR Buy $24
Jun-25-19Initiated Stifel Buy
Apr-29-19Initiated Goldman Buy $22
Apr-29-19Initiated Cowen Outperform $25
Apr-29-19Initiated Citigroup Buy $29
Aug-29-20 07:20AM  
Aug-18-20 08:00AM  
Aug-12-20 05:45PM  
04:05PM  
Aug-11-20 10:30AM  
10:26AM  
Aug-07-20 08:30AM  
Aug-03-20 12:31PM  
Jul-31-20 08:00AM  
Jul-27-20 08:00AM  
Jul-05-20 05:56PM  
Jun-18-20 08:50AM  
Jun-08-20 08:00AM  
May-29-20 04:05PM  
May-27-20 04:05PM  
May-13-20 05:35PM  
04:05PM  
May-08-20 04:05PM  
May-06-20 09:55AM  
Apr-07-20 10:59AM  
Apr-03-20 01:10PM  
Mar-17-20 04:05PM  
Mar-16-20 10:01AM  
Mar-09-20 04:30PM  
Feb-27-20 08:42AM  
Feb-26-20 04:42PM  
Feb-25-20 08:00AM  
Feb-24-20 05:47PM  
08:00AM  
Feb-23-20 04:00PM  
Feb-11-20 08:00AM  
Feb-05-20 04:11PM  
Dec-17-19 05:43PM  
Dec-05-19 05:00PM  
Nov-20-19 06:10PM  
07:21AM  
Nov-15-19 10:20AM  
Nov-14-19 08:00AM  
Nov-12-19 04:05PM  
Nov-11-19 09:28AM  
07:50AM  
Nov-07-19 10:15AM  
Nov-04-19 10:35AM  
Oct-29-19 07:00AM  
Oct-28-19 05:49PM  
Oct-18-19 07:00PM  
12:14PM  
Oct-11-19 05:10PM  
Oct-07-19 08:00AM  
Oct-06-19 04:00PM  
Oct-03-19 07:00AM  
Sep-19-19 12:27PM  
Aug-26-19 05:46AM  
Aug-12-19 04:05PM  
Jul-21-19 11:10AM  
Jul-11-19 10:28AM  
Jun-10-19 07:00AM  
Jun-05-19 07:00AM  
Apr-08-19 04:30PM  
Apr-05-19 02:52PM  
Apr-03-19 08:58PM  
Mar-31-19 08:30AM  
Mar-29-19 06:00AM  
NGM Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases. The company's product candidates include Aldafermin, an engineered variant of the FGF19 human hormone in Phase 2b clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); NGM313, an agonistic antibody that activates fibroblast growth factor receptor 1c-beta-klotho, which is in Phase 1b clinical trial for use in the treatment of type 2 diabetes and NASH; and NGM395, which is engineered variant of the GDF15 human hormone for use in the treatment of metabolic syndrome. Its products under development also comprise NGM120, an inhibitory antibody binding glial cell-derived neurotrophic factor receptor alpha-like that is in Phase 1 clinical trials to inhibit the effects of elevated GDF15 levels on cancer anorexia/cachexia syndrome; NGM217, an antibody in Phase 1 clinical trials to restore pancreatic islet function and increase insulin production in patients with diabetes; and NGM621, an antibody in Phase 1 clinical trials to decrease levels of a protein implicated in the dry form of AMD. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLUMN GROUP L PDirectorSep 02Buy17.6727,595487,6041,827,025Sep 03 05:31 PM
COLUMN GROUP L PDirectorSep 02Buy17.6727,595487,6041,827,025Sep 03 05:32 PM
COLUMN GROUP L PDirectorSep 01Buy17.6436,494643,7541,799,430Sep 03 05:31 PM
COLUMN GROUP L PDirectorSep 01Buy17.6436,494643,7541,799,430Sep 03 05:32 PM
CHEN JIN-LONGChief Scientific OfficerSep 01Sale17.8325,000445,829970,005Sep 03 04:18 PM
COLUMN GROUP L PDirectorAug 28Buy17.8926,135467,5551,762,936Aug 31 05:02 PM
COLUMN GROUP L PDirectorAug 28Buy17.8926,135467,5551,762,936Aug 31 05:00 PM
COLUMN GROUP L PDirectorAug 27Buy17.7936,359646,8271,736,801Aug 31 05:00 PM
COLUMN GROUP L PDirectorAug 27Buy17.7936,359646,8271,736,801Aug 31 05:02 PM
COLUMN GROUP L PDirectorAug 25Buy18.001001,8001,700,442Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 25Buy18.001001,8001,700,442Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 24Buy17.9611,024197,9911,700,342Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 24Buy17.9611,024197,9911,700,342Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 21Buy17.977,321131,5581,689,318Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 21Buy17.977,321131,5581,689,318Aug 25 06:50 PM
COLUMN GROUP L PDirectorAug 17Buy17.896,425114,9431,681,997Aug 17 07:11 PM
COLUMN GROUP L PDirectorAug 17Buy17.896,425114,9431,681,997Aug 17 07:12 PM
COLUMN GROUP L PDirectorAug 14Buy17.4937,993664,4981,675,572Aug 17 07:12 PM
COLUMN GROUP L PDirectorAug 14Buy17.4937,993664,4981,675,572Aug 17 07:11 PM
COLUMN GROUP L PDirectorAug 13Buy17.8919,895355,9221,637,579Aug 17 07:11 PM
COLUMN GROUP L PDirectorAug 13Buy17.8919,895355,9221,637,579Aug 17 07:12 PM
CHEN JIN-LONGChief Scientific OfficerAug 10Sale19.0225,000475,500995,005Aug 11 04:30 PM
COLUMN GROUP L PDirectorJul 30Buy17.9973213,1691,617,684Aug 03 05:57 PM
COLUMN GROUP L PDirectorJul 30Buy17.9973213,1691,617,684Aug 03 05:54 PM
COLUMN GROUP L PDirectorJul 28Buy17.994,10573,8491,616,952Jul 30 08:08 PM
COLUMN GROUP L PDirectorJul 28Buy17.994,10573,8491,616,952Jul 30 07:23 PM
COLUMN GROUP L PDirectorJul 27Buy17.993,83468,9741,612,847Jul 28 05:39 PM
COLUMN GROUP L PDirectorJul 27Buy17.993,83468,9741,612,847Jul 28 05:40 PM
COLUMN GROUP L PDirectorJul 24Buy17.9368,7491,232,6701,609,013Jul 28 05:40 PM
COLUMN GROUP L PDirectorJul 24Buy17.9368,7491,232,6701,609,013Jul 28 05:39 PM
COLUMN GROUP L PDirectorJul 22Buy18.001933,4741,540,264Jul 23 05:39 PM
COLUMN GROUP L PDirectorJul 22Buy18.001933,4741,540,264Jul 23 05:44 PM
COLUMN GROUP L PDirectorJul 21Option Exercise13.3524,000320,40044,000Jul 23 05:39 PM
COLUMN GROUP L PDirectorJul 21Option Exercise13.3524,000320,40044,000Jul 23 05:44 PM
CHEN JIN-LONGChief Scientific OfficerJul 01Sale18.9125,000472,7281,020,005Jul 02 04:36 PM
CHEN JIN-LONGChief Scientific OfficerJun 15Sale21.6525,000541,1661,045,005Jun 17 06:31 PM
Lieu Hsiao DSVP, Chief Medical OfficerMay 15Sale22.001,56234,364182May 18 04:35 PM
Svennilson PeterDirectorApr 08Buy14.95112,6021,683,40017,706,978Apr 09 05:56 PM
GOEDDEL DAVID VDirectorApr 08Buy14.95112,6021,683,40017,896,978Apr 09 05:54 PM
COLUMN GROUP L P10% OwnerApr 08Buy14.95112,6021,683,4001,540,071Apr 09 05:53 PM
COLUMN GROUP L P10% OwnerApr 08Buy14.95112,6021,683,4001,540,071Apr 09 05:52 PM
COLUMN GROUP L P10% OwnerApr 07Buy14.38123,7281,779,2091,427,469Apr 07 07:23 PM
COLUMN GROUP L P10% OwnerApr 07Buy14.38123,7281,779,2091,427,469Apr 07 07:21 PM
GOEDDEL DAVID VDirectorApr 07Buy14.38123,7281,779,20917,784,376Apr 07 07:26 PM
Svennilson PeterDirectorApr 07Buy14.38123,7281,779,20917,594,376Apr 07 07:28 PM
Svennilson PeterDirectorApr 03Buy12.4114,587181,02517,470,648Apr 07 07:28 PM
GOEDDEL DAVID VDirectorApr 03Buy12.4114,587181,02517,660,648Apr 07 07:26 PM
COLUMN GROUP L P10% OwnerApr 03Buy12.4114,587181,0251,303,741Apr 07 07:21 PM
COLUMN GROUP L P10% OwnerApr 03Buy12.4114,587181,0251,303,741Apr 07 07:23 PM
GOEDDEL DAVID VDirectorApr 02Buy12.4014,850184,14017,646,061Apr 02 06:14 PM
Svennilson PeterDirectorApr 02Buy12.4014,850184,14017,456,061Apr 02 06:16 PM
COLUMN GROUP L P10% OwnerApr 02Buy12.4014,850184,1401,289,154Apr 02 06:08 PM
COLUMN GROUP L P10% OwnerApr 02Buy12.4014,850184,1401,289,154Apr 02 06:07 PM
COLUMN GROUP L P10% OwnerApr 01Buy12.26118,0671,447,5011,274,304Apr 02 06:07 PM
COLUMN GROUP L P10% OwnerApr 01Buy12.26118,0671,447,5011,274,304Apr 02 06:08 PM
Svennilson PeterDirectorApr 01Buy12.26118,0671,447,50117,441,211Apr 02 06:16 PM
GOEDDEL DAVID VDirectorApr 01Buy12.26118,0671,447,50117,631,211Apr 02 06:14 PM
GOEDDEL DAVID VDirectorMar 31Buy12.53118,0671,479,38017,513,144Apr 02 06:14 PM
Svennilson PeterDirectorMar 31Buy12.53118,0671,479,38017,323,144Apr 02 06:16 PM
COLUMN GROUP L P10% OwnerMar 31Buy12.53118,0671,479,3801,156,237Apr 02 06:08 PM
COLUMN GROUP L P10% OwnerMar 31Buy12.53118,0671,479,3801,156,237Apr 02 06:07 PM
Svennilson PeterDirectorMar 25Buy12.492,41630,17617,205,077Mar 25 07:45 PM
COLUMN GROUP L P10% OwnerMar 25Buy12.492,41630,1761,038,170Mar 25 07:42 PM
COLUMN GROUP L P10% OwnerMar 25Buy12.492,41630,1761,038,170Mar 25 07:41 PM
GOEDDEL DAVID VDirectorMar 25Buy12.492,41630,17617,395,077Mar 25 07:43 PM
GOEDDEL DAVID VDirectorMar 24Buy12.22128,3771,568,76717,392,661Mar 25 07:43 PM
COLUMN GROUP L P10% OwnerMar 24Buy12.22128,3771,568,7671,035,754Mar 25 07:41 PM
COLUMN GROUP L P10% OwnerMar 24Buy12.22128,3771,568,7671,035,754Mar 25 07:42 PM
Svennilson PeterDirectorMar 24Buy12.22128,3771,568,76717,202,661Mar 25 07:45 PM
Svennilson PeterDirectorMar 23Buy11.63170,3871,981,60117,074,284Mar 25 07:45 PM
COLUMN GROUP L P10% OwnerMar 23Buy11.63170,3871,981,601907,377Mar 25 07:42 PM
COLUMN GROUP L P10% OwnerMar 23Buy11.63170,3871,981,601907,377Mar 25 07:41 PM
GOEDDEL DAVID VDirectorMar 23Buy11.63170,3871,981,60117,264,284Mar 25 07:43 PM
COLUMN GROUP L P10% OwnerMar 20Buy11.77143,0821,684,075736,990Mar 23 05:04 PM
COLUMN GROUP L P10% OwnerMar 20Buy11.77143,0821,684,075736,990Mar 23 05:06 PM
GOEDDEL DAVID VDirectorMar 20Buy11.77143,0821,684,07517,093,897Mar 23 05:08 PM
Svennilson PeterDirectorMar 20Buy11.77143,0821,684,07516,903,897Mar 23 05:09 PM
Svennilson PeterDirectorMar 19Buy11.59148,4641,720,69816,760,815Mar 23 05:09 PM
GOEDDEL DAVID VDirectorMar 19Buy11.59148,4641,720,69816,950,815Mar 23 05:08 PM
COLUMN GROUP L P10% OwnerMar 19Buy11.59148,4641,720,698593,908Mar 23 05:06 PM
COLUMN GROUP L P10% OwnerMar 19Buy11.59148,4641,720,698593,908Mar 23 05:04 PM
GOEDDEL DAVID VDirectorMar 05Buy18.008,307149,52616,802,351Mar 06 05:57 PM
Svennilson PeterDirectorMar 05Buy18.008,307149,52616,612,351Mar 06 05:59 PM
COLUMN GROUP L P10% OwnerMar 05Buy18.008,307149,526445,444Mar 06 06:01 PM
COLUMN GROUP L P10% OwnerMar 05Buy18.008,307149,526445,444Mar 06 06:00 PM
COLUMN GROUP L P10% OwnerMar 04Buy17.969,986179,349437,137Mar 04 07:28 PM
COLUMN GROUP L P10% OwnerMar 04Buy17.969,986179,349437,137Mar 04 07:29 PM
Svennilson PeterDirectorMar 04Buy17.969,986179,34916,604,044Mar 04 07:26 PM
GOEDDEL DAVID VDirectorMar 04Buy17.969,986179,34916,794,044Mar 04 07:24 PM
GOEDDEL DAVID VDirectorMar 03Buy17.9938,758697,25616,784,058Mar 04 07:24 PM
Svennilson PeterDirectorMar 03Buy17.9938,758697,25616,594,058Mar 04 07:26 PM
COLUMN GROUP L P10% OwnerMar 03Buy17.9938,758697,256427,151Mar 04 07:29 PM
COLUMN GROUP L P10% OwnerMar 03Buy17.9938,758697,256427,151Mar 04 07:28 PM
COLUMN GROUP L P10% OwnerMar 02Buy17.9014,124252,820388,393Mar 04 07:28 PM
COLUMN GROUP L P10% OwnerMar 02Buy17.9014,124252,820388,393Mar 04 07:29 PM
Svennilson PeterDirectorMar 02Buy17.9014,124252,82016,555,300Mar 04 07:26 PM
GOEDDEL DAVID VDirectorMar 02Buy17.9014,124252,82016,745,300Mar 04 07:24 PM
COLUMN GROUP L P10% OwnerFeb 28Buy17.9137,800676,998374,269Feb 28 07:12 PM
COLUMN GROUP L P10% OwnerFeb 28Buy17.9137,800676,998374,269Feb 28 07:10 PM
Svennilson PeterDirectorFeb 28Buy17.9137,800676,99816,541,176Feb 28 07:09 PM